glp 1 drugs generic Letter: Association Between Incretin Mimetics and Medullary Thyroid Cancer FDA approves 1st generic GLP-1
Description
Cardiovascular protective properties of incretin-based therapies in type 2 diabetes
37.7%, HR = 0.23, 95% CI 0.210.26) [58]
( 10.1161/CIRCRESAHA.114.301958) [DOI] [PubMed] [Google Scholar] 35.Lovshin JA, Barnie A, DeAlmeida A, Logan A, Zinman B, Drucker DJ
10.1210/10.1210/er.2006-0038 126 WangX.ZhouJ.DoyleM
doi: 10.1186/s13195-024-01666-7
A total of 181,238 AE reports with treatment with GLP-1 RAs were documented in the FAERS database, of which 8,240 were psychiatric AEs
